Acadia acquires six U.K. facilities

Summer buying spree adds nearly 700 beds to U.K. operations
Sep 2, 2015 10:52 AM

Leerink sees big bounce for Acadia

Leerink Swann analyst Ana Gupte has launched coverage of Acadia Healthcare with an 'outperform' rating and a $90 price target that gives investors 25 percent of upside from where the shares (Ticker: ACHC) closed on Tuesday. She sees the Franklin-based company beating the Street's consensus EBITDA numbers both this year and next.

Sep 2, 2015 7:29 AM

NY investment firm bets big on AAC rebound

Health care specialists have quadrupled stake since end of June
Aug 24, 2015 7:02 AM

AAC CEO: California indictment not hurting business

Addiction treatment company bringing in outsiders to assess operations
Aug 21, 2015 7:38 AM

Jefferies sees 20%+ rise in Acadia

Analyst Brian Tanquilut at Jefferies & Co. sees many bright days ahead for Acadia Healthcare investors. Following the company's second-quarter earnings report, he has raised his price target for the stock to $100 from $88. That leaves a lot of upside: Acadia (Ticker: ACHC) closed last week's trading at $81.02 and is to $81.84 this afternoon.

Aug 17, 2015 2:13 PM

More local health care insiders book big stock profits

HCA, AmSurg, Acadia execs take home $7M+
Aug 12, 2015 7:17 AM

Acadia shareholders prep $400M stock sale

Jacobs, other insiders selling about $19M worth of shares
Aug 11, 2015 7:07 AM

Avondale analyst lifts Acadia target, sees potential in CHS trends

Analyst Paula Torch at Avondale Partners has raised her price target for shares of Acadia Healthcare following the company's second-quarter profit report. The Franklin-based behavioral health care provider is ahead of plan this year in adding beds to its facilities, and new projects will add to the company's ability to grow its top line to $4 billion by 2018. Torch also says margins — especially at the company's United Kingdom and acquired CRC operations — still have upside. That has led her to lift her target for Acadia, which closed Friday (Ticker: ACHC) at $81.78, to $96 from $84. Year to date, they're up more than 30 percent.

Though still highly leveraged, ACHC has consistently demonstrated its ability to generate cash from its current portfolio, and we expect continued solid operating cash flow in 2015 and 2016 to help ACHC execute on deals.

Torch also has taken stock of Community Health Systems' Q2 results and outlook. She's sticking with her 'outperform' rating even though volume and pricing trends "continue to lag peers," mostly due to hospitals previously owned by Health Management Associates. But the factors holding down CHS' valuation — its higher leverage and integration risks, among others — "are starting to mitigate and show signs of improvement," Torch writes. She still sees CHS (Ticker: CYH) climbing to $77 from the $56 and change at which it ended last week.

Aug 10, 2015 9:53 AM

Avondale analyst cuts AAC price target in half

Firm upholds buy rating after California indictment
Aug 7, 2015 12:59 PM

AAC CEO, director spend nearly $700K on beaten-up shares

Stock up slightly in pre-market trading
Aug 5, 2015 7:34 AM